Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85%
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
PP&E Net
$43.6m
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
7%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
PP&E Net
$5.9m
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
PP&E Net
$1.7m
CAGR 3-Years
-21%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
PP&E Net
$381k
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
PP&E Net
â‚Ş17m
CAGR 3-Years
113%
CAGR 5-Years
19%
CAGR 10-Years
28%
Pluri Inc
NASDAQ:PLUR
PP&E Net
$7.2m
CAGR 3-Years
61%
CAGR 5-Years
8%
CAGR 10-Years
-4%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's PP&E Net?
PP&E Net
43.6m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's PP&E Net amounts to 43.6m USD.

What is Kamada Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
7%

Over the last year, the PP&E Net growth was 33%. The average annual PP&E Net growth rates for Kamada Ltd have been 14% over the past three years , 9% over the past five years , and 7% over the past ten years .

Back to Top